Century Therapeutics (IPSC) Cash & Equivalents (2020 - 2026)
Century Therapeutics' Cash & Equivalents was $49.64 million in Q2 2026, down 12.7% from $56.88 million a year earlier and down 2.8% from the prior quarter.
Century Therapeutics (IPSC) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Century Therapeutics came in at $61.85 million, up 5.8% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 17.8% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $58.44 million in FY2024 (+23.5%), $47.32 million in FY2023 (-43.8%), $84.27 million in FY2022 (+49.3%) and $56.45 million in FY2021 (+107.4%).
- The Q2 2026 figure marks the lowest quarterly Cash & Equivalents since Q2 2024.
- Compared with a year earlier, Cash & Equivalents was higher in five of the last eight quarters, with growth averaging 8.0%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q4 2021 (growth of 107.4%); the worst was Q2 2022 (a decline of 58.6%).
- Per Business Quant data, IPSC's Cash & Equivalents in the three quarters before Q2 2026 was $51.05 million (Q1 2026), $61.85 million (Q4 2025) and $55.52 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Century Therapeutics | 308.74 Mn | -195.64 Mn | - | 49.64 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.64 Mn |
| Mar 31, 2026 | 51.05 Mn |
| Dec 31, 2025 | 61.85 Mn |
| Sep 30, 2025 | 55.52 Mn |
| Jun 30, 2025 | 56.88 Mn |
| Mar 31, 2025 | 51.87 Mn |
| Dec 31, 2024 | 58.44 Mn |
| Sep 30, 2024 | 52.59 Mn |
| Jun 30, 2024 | 41.46 Mn |
| Mar 31, 2024 | 46.81 Mn |
| Dec 31, 2023 | 47.32 Mn |
| Sep 30, 2023 | 55.31 Mn |
| Jun 30, 2023 | 64.44 Mn |
| Mar 31, 2023 | 86.83 Mn |
| Dec 31, 2022 | 84.27 Mn |
| Sep 30, 2022 | 111.35 Mn |
| Jun 30, 2022 | 112.79 Mn |
| Mar 31, 2022 | 126.04 Mn |
| Dec 31, 2021 | 56.45 Mn |
| Sep 30, 2021 | 101.29 Mn |
Century Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IPSC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "IPSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IPSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();